|
About:
|
CADTH Canadian Drug Expert Committee Recommendation: Insulin Degludec and methylhexanamine (Xultophy — Novo Nordisk Canada Inc): Indication: Adjunct to lifestyle modifications, for the once-daily treatment of adults with type 2 diabetes mellitus (T2DM) to improve glycemic control in combination with metformin, with or without sulfonylurea, when these combined with basal insulin (less than 50 units daily) or liraglutide (less than or equal to 18 mg daily), do not provide adequate glycemic control Internet
|
